This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sokoloski, J. A. Articles by Sartorelli, A. C. Search for Related Content PubMed PubMed Citation Articles by Sokoloski, J. A. Articles by Sartorelli, A. C.

Alterations in Glycoprotein Synthesis and Guanosine Triphosphate Levels Associated with the Differentiation of HL-60 Leukemia Cells Produced by Inhibitors of Inosine 5'-Phosphate Dehydrogenase¹

Department of Pharmacology and Developmental Therapeutics Program, Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510

The synthetic "C" nucleoside, tiazofurin (2-ß-D-ribofuranosylthiazole-4-carboxamide), its selenium analogue selenazofurin, and the related inhibitor of inosine 5'-phosphate (IMP) dehydrogenase, mycophenolic acid, are effective inducers of the terminal differentiation of HL-60 promyelocytic leukemia cells. The inhibition of cellular replication and the induced maturation produced by these agents appears to be a consequence of the inhibition of IMP dehydrogenase, since growth inhibition is partially reversed, and differentiation is completely prevented by the simultaneous exposure of cells treated with inhibitors of IMP dehydrogenase to exogenous guanosine, which serves to circumvent the effects of the blockage of IMP dehydrogenase. The exposure of HL-60 leukemia cells to inhibitors of IMP dehydrogenase caused a marked reduction in the incorporation of [³H]mannose into both cellular glycoproteins and their lipid-linked ligosaccharide precursors; these effects are presumably due to the pronounced decrease in intracellular levels of guanosine triphosphate produced by blockage of IMP dehydrogenase. Maximum effects on glycoprotein biosynthesis occurred within 8 h of exposure to the inhibitors of IMP dehydrogenase. The simultaneous incubation of cells with guanosine and these inducers of differentiation partially prevented the reduction in [³H]mannose incorporation into glycoproteins, supporting a relationship between glycoprotein biosynthesis and guanosine triphosphate formation in the induction of differentiation by inhibitors of IMP dehydrogenase.

¹ This research was supported in part by USPHS Grant CA-02817 from the National Cancer Institute.

Received 8/26/85. Revised 12/17/85. Accepted 1/21/86.

This article has been cited by other articles:

				W T Gibson and M R Hayden Mycophenolate mofetil and animal models Lupus, November 1, 2006; 15(11_suppl): 27 - 34. [Abstract] [PDF]

				N. Takebe, X. Cheng, T. E. Fandy, R. K. Srivastava, S. Wu, S. Shankar, K. Bauer, J. Shaughnessy, and G. Tricot IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells. Mol. Cancer Ther., February 1, 2006; 5(2): 457 - 466. [Abstract] [Full Text] [PDF]

				K. Stegmaier, S. M. Corsello, K. N. Ross, J. S. Wong, D. J. DeAngelo, and T. R. Golub Gefitinib induces myeloid differentiation of acute myeloid leukemia Blood, October 15, 2005; 106(8): 2841 - 2848. [Abstract] [Full Text] [PDF]

				N. Takebe, X. Cheng, S. Wu, K. Bauer, O. G. Goloubeva, R. G. Fenton, M. Heyman, A. P. Rapoport, A. Badros, J. Shaughnessy, et al. Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients Clin. Cancer Res., December 15, 2004; 10(24): 8301 - 8308. [Abstract] [Full Text] [PDF]

				A. G. Zimmermann, K. L. Wright, J. P.-Y. Ting, and B. S. Mitchell Regulation of Inosine-5'-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells. ROLE FOR A NOVEL 5' PALINDROMIC OCTAMER SEQUENCE J. Biol. Chem., September 5, 1997; 272(36): 22913 - 22923. [Abstract] [Full Text] [PDF]

				S. A. Flanagan and K. A. Meckling-Gill Characterization of a Novel Na+-dependent, Guanosine-specific, Nitrobenzylthioinosine-sensitive Transporter in Acute Promyelocytic Leukemia Cells J. Biol. Chem., July 18, 1997; 272(29): 18026 - 18032. [Abstract] [Full Text] [PDF]

				A. G. Zimmermann, J. Spychala, and B. S. Mitchell Characterization of the Human Inosine-5`-monophosphate Dehydrogenase Type II Gene J. Biol. Chem., March 24, 1995; 270(12): 6808 - 6814. [Abstract] [Full Text] [PDF]